Aug 29, 2011 08:20 EDT nxt2b (Nexttobe AB) an investment company owned by Bengt Ågerup, has today signed an agreement with a group of shareholders in Olink AB to purchase 49 % of the outstanding shares in the company. The intention is to accelerate the growth and value creation of the company by injecting knowledge, experience and financial strength to complement Olink’s unique product and technology position.
Tag: biomarkers
Press Releases
Apr 27, 2011 09:21 EDT Proseek™ is a user friendly open assay development reagent kit for the detection and quantification of proteins in serum or plasma samples. It offers the same level of performance as ELISA, but uses extremely low sample volumes; only1 µl is required for each reaction thus enabling the scientist to study precious bio-banked materials and plasma from small laboratory animals.
Mar 24, 2011 04:00 EDT Olink Bioscience has signed a distributorship agreement with Sapphire Bioscience for the distribution of the Duolink® product line in Australia and New Zealand.
Videos
Sep 25, 2009 05:20 EDT
The Duolink® kit from Olink Bioscience enables researchers to use existing antibodies to detect single molecular events, such as protein interactions in unmodified cells and tissue sections. Duolink is based on in situ PLA™ which has the resolution and sensitivity to visualize post-translational modifications and protein interactions, which are fundamental processes in cell signaling pathways.
Length 43:12
Contact persons
Previously Dr Gullberg worked for 10 years at Uppsala University where he also earned his Ph.D. The focus of his work since 1999 has been proximity ligation, rolling circle amplification and selector technology, all core technologies of Olink Bioscience.
